(22r)-22-hydroxycholesterol has been researched along with cholestane-3,5,6-triol, (3beta, 5alpha, 6beta)-isomer in 2 studies
| Studies ((22r)-22-hydroxycholesterol) | Trials ((22r)-22-hydroxycholesterol) | Recent Studies (post-2010) ((22r)-22-hydroxycholesterol) | Studies (cholestane-3,5,6-triol, (3beta, 5alpha, 6beta)-isomer) | Trials (cholestane-3,5,6-triol, (3beta, 5alpha, 6beta)-isomer) | Recent Studies (post-2010) (cholestane-3,5,6-triol, (3beta, 5alpha, 6beta)-isomer) |
|---|---|---|---|---|---|
| 15 | 0 | 8 | 7 | 0 | 6 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dodo, K; Hashimoto, Y; Karaki, F; Ohgane, K | 1 |
| Dodo, K; Hashimoto, Y; Karaki, F; Noguchi-Yachide, T; Ohgane, K | 1 |
2 other study(ies) available for (22r)-22-hydroxycholesterol and cholestane-3,5,6-triol, (3beta, 5alpha, 6beta)-isomer
| Article | Year |
|---|---|
Structure-activity relationship studies of Niemann-Pick type C1-like 1 (NPC1L1) ligands identified by screening assay monitoring pharmacological chaperone effect.
Topics: Anticholesteremic Agents; Azetidines; Binding Sites; Biological Transport; Carbamates; Ezetimibe; HEK293 Cells; Humans; Ligands; Membrane Proteins; Membrane Transport Proteins; Mutation; Steroids; Structure-Activity Relationship | 2013 |
Structure-activity relationships of oxysterol-derived pharmacological chaperones for Niemann-Pick type C1 protein.
Topics: Carrier Proteins; Dose-Response Relationship, Drug; Humans; Intracellular Signaling Peptides and Proteins; Membrane Glycoproteins; Molecular Structure; Mutation; Niemann-Pick C1 Protein; Niemann-Pick Disease, Type C; Sterols; Structure-Activity Relationship | 2014 |